J. Xiang

发表

Src-family kinases negatively regulate NFAT signaling in resting human T cells

A. Baer, J. Stapleton, Winston Colon-Moran, 2017, PloS one.

An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells

J. McLinden, J. Stapleton, J. Xiang, 2006, Proceedings of the National Academy of Sciences.

Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MlP-lα, MIP-1β, and SDF-1

S. Wünschmann, J. Stapleton, S. L. George, 2004, The Lancet.

Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation

J. McLinden, J. Stapleton, N. Bhattarai, 2015, PLoS pathogens.

Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication.

J. McLinden, J. Stapleton, J. Xiang, 2008, The Journal of infectious diseases.

GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.

M. Gale, J. Stapleton, D. Labrecque, 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis.

J. Cerhan, A. Feldman, T. Habermann, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.

J. McLinden, J. Stapleton, K. Murthy, 2013, The Journal of general virology.

GB Virus C Envelope Protein E2 Inhibits TCR-Induced IL-2 Production and Alters IL-2–Signaling Pathways

J. McLinden, J. Stapleton, N. Bhattarai, 2012, The Journal of Immunology.

GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals.

P. Polgreen, J. Stapleton, J. Xiang, 2003, Microbes and infection.

Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures.

J. Stapleton, S. L. George, J. Xiang, 2003, Virology.

Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding

M. Houghton, J. McLinden, J. Stapleton, 2006, Journal of Virology.

T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2

J. L. Welch, J. Houtman, J. Stapleton, 2021, The Journal of Infectious Diseases.

Inactivation of Severe Acute Respiratory Coronavirus Virus 2 (SARS-CoV-2) and Diverse RNA and DNA Viruses on Three-Dimensionally Printed Surgical Mask Materials

J. L. Welch, S. Perlman, P. O’Shaughnessy, 2020, Infection Control & Hospital Epidemiology.

Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co‐expressing HCV core protein and CYP2E1

A. Branch, D. Spitz, B. Britigan, 2004, Journal of medical virology.

Recombinant hepatitis C virus‐like particles expressed by baculovirus: Utility in cell‐binding and antibody detection assays

J. Stapleton, D. Labrecque, S. L. George, 2002, Journal of medical virology.

GB Virus Type C: a Beneficial Infection?

J. Stapleton, J. Xiang, C. Williams, 2004, Journal of Clinical Microbiology.

The GBV-C envelope glycoprotein E2 does not interact specifically with CD81

J. McLinden, J. Stapleton, J. Xiang, 2007, AIDS.

A novel T cell evasion mechanism in persistent RNA virus infection.

J. McLinden, J. Stapleton, N. Bhattarai, 2014, Transactions of the American Clinical and Climatological Association.

[Cordyceps sinensis protects HK2 cells from ischemia-reperfusion injury through Sirt1 pathway].

X. Ao, J. Xiang, Qiao-ling Zhou, 2017, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function.

J. McLinden, J. Stapleton, N. Bhattarai, 2015, Virology.

GB Virus Type C Envelope Protein E2 Elicits Antibodies That React with a Cellular Antigen on HIV-1 Particles and Neutralize Diverse HIV-1 Isolates

D. Montefiori, J. McLinden, J. Stapleton, 2010, The Journal of Immunology.

Diverse HIV-1 Isolates Antigen on HIV-1 Particles and Neutralize Antibodies That React with a Cellular GB Virus Type C Envelope Protein E2 Elicits

Donna, D. Montefiori, M. Kaufman, 2010 .

Cells + Human CD4 Expression and Inhibit HIV Replication in Decrease CD4 Flaviviridae Viruses within the

J. McLinden, J. Stapleton, J. Xiang, 2009 .

Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line.

J. McLinden, J. Stapleton, J. Xiang, 2007, The Journal of general virology.

HIV and GB virus C coinfection.

J. Stapleton, J. Xiang, C. Williams, 2006, The Lancet. Infectious diseases.

South African GB virus C isolates: interactions between genotypes 1 and 5 isolates and HIV.

J. McLinden, J. Stapleton, J. Xiang, 2005, The Journal of infectious diseases.

Glycerol Monolaurate, an Analogue to a Factor Secreted by Lactobacillus, Is Virucidal against Enveloped Viruses, Including HIV-1

J. L. Welch, P. Schlievert, J. Stapleton, 2020, mBio.

Yellow Fever Virus, but Not Zika Virus or Dengue Virus, Inhibits T-Cell Receptor–Mediated T-Cell Function by an RNA-Based Mechanism

J. Houtman, F. Sutterwala, S. Cassel, 2017, The Journal of infectious diseases.

GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy

K. Chaloner, J. Fahey, R. Pollard, 2009, AIDS.

Effect of Primer Selection on Estimates of GB Virus C (GBV-C) Prevalence and Response to Antiretroviral Therapy for Optimal Testing for GBV-C Viremia

K. Chaloner, J. Stapleton, R. Diaz, 2006, Journal of Clinical Microbiology.

Optimal Testing for GBV-C Viremia Response to Antiretroviral Therapy for GB Virus C ( GBV-C ) Prevalence and Effect of Primer Selection on Estimates of

K. Chaloner, J. Stapleton, J. Xiang, 2006 .

Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.

J. Stapleton, S. L. George, J. Xiang, 2004, Lancet.

GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression.

J. McLinden, J. Stapleton, J. Xiang, 2012, The Journal of infectious diseases.

GB Virus C Infection Is Associated with Altered Lymphocyte Subset Distribution and Reduced T Cell Activation and Proliferation in HIV-Infected Individuals

K. Chaloner, A. Landay, J. Stapleton, 2012, PloS one.

Interactions between GB virus type C and HIV

J. Stapleton, S. L. George, J. Xiang, 2002, Current infectious disease reports.

Effect of coinfection with GB virus C on survival among patients with HIV infection.

S. Wünschmann, D. Diekema, J. Stapleton, 2001, The New England journal of medicine.

Visualization and characterization of GB virus‐C particles: evidence for a nucleocapsid

D. Soll, K. Daniels, D. Labrecque, 1999, Journal of viral hepatitis.

Urban Particulate Matter Impairment of Airway Surface Liquid–Mediated Coronavirus Inactivation

J. L. Welch, M. Nonnenmann, A. Comellas, 2021, The Journal of infectious diseases.

airway-surface-liquid-mediated coronavirus inactivation

M. Nonnenmann, A. Comellas, J. Zabner, 2021 .

Human Pegivirus infection and lymphoma risk and prognosis: a North American study

J. Cerhan, Y. Asmann, A. Feldman, 2018, British journal of haematology.

Persistent GB virus C infection and survival in HIV-infected men.

J. Margolick, J. Phair, P. Polgreen, 2004, The New England journal of medicine.

GB Virus C Particles Inhibit T Cell Activation via Envelope E2 Protein-Mediated Inhibition of TCR Signaling

A. Landay, J. McLinden, J. Stapleton, 2013, The Journal of Immunology.

Inhibition of TCR Signaling Protein-MediatedActivation via Envelope E 2 GB Virus C Particles Inhibit T

A. Landay, J. McLinden, J. Stapleton, 2013 .

Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4+ Cells1

J. McLinden, J. Stapleton, J. Xiang, 2009, The Journal of Immunology.

Full-Length GB Virus C (Hepatitis G Virus) RNA Transcripts Are Infectious in Primary CD4-Positive T Cells

J. Stapleton, J. Xiang, W. Schmidt, 2000, Journal of Virology.

The natural history of non-human GB virus C in captive chimpanzees

J. McLinden, J. Stapleton, K. Murthy, 2011, The Journal of general virology.

Characterization of Hepatitis G Virus (GB-C Virus) Particles: Evidence for a Nucleocapsid and Expression of Sequences Upstream of the E1 Protein

Jack T. Stapleton, R. Gish, J. McLinden, 1998, Journal of Virology.

Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge

H. Liao, B. Haynes, N. Haigwood, 2017, Journal of Virology.

Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo

J. McLinden, J. Stapleton, N. Bhattarai, 2017, PLoS pathogens.

Characterization of a Peptide Domain within the GB Virus C NS5A Phosphoprotein that Inhibits HIV Replication

J. McLinden, J. Stapleton, J. Xiang, 2008, PloS one.

Ethnicity and Smoking-Associated DNA Methylation Changes at HIV Co-Receptor GPR15

S. Beach, F. Gibbons, C. Cutrona, 2015, Front. Psychiatry.

GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals

A. Landay, J. Stapleton, J. Xiang, 2013, AIDS.

Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.

J. McLinden, J. Stapleton, E. Mohr, 2012, Virology.

T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2

J. L. Welch, J. Houtman, J. Stapleton, 2021, The Journal of infectious diseases.

Inactivation of Severe Acute Respiratory Coronavirus Virus 2 (SARS-CoV-2) and Diverse RNA and DNA Viruses on Three-Dimensionally Printed Surgical Mask Materials

J. L. Welch, S. Perlman, P. O’Shaughnessy, 2020, Infection control and hospital epidemiology.

Characterization of performance and disinfection resilience of nonwoven filter materials for use in 3D-printed N95 respirators

P. O’Shaughnessy, P. Thorne, J. Stapleton, 2021, Journal of occupational and environmental hygiene.